Your browser doesn't support javascript.
loading
Thrombectomy in Stroke Patients With Low Alberta Stroke Program Early Computed Tomography Score: Is Modified Thrombolysis in Cerebral Infarction (mTICI) 2c/3 Superior to mTICI 2b?
Elawady, Sameh Samir; Saway, Brian Fabian; Matsukawa, Hidetoshi; Uchida, Kazutaka; Lin, Steven; Maier, Ilko; Jabbour, Pascal; Kim, Joon-Tae; Wolfe, Stacey Quintero; Rai, Ansaar; Starke, Robert M; Psychogios, Marios-Nikos; Samaniego, Edgar A; Arthur, Adam; Yoshimura, Shinichi; Cuellar, Hugo; Grossberg, Jonathan A; Alawieh, Ali; Romano, Daniele G; Tanweer, Omar; Mascitelli, Justin; Fragata, Isabel; Polifka, Adam; Osbun, Joshua; Crosa, Roberto; Matouk, Charles; Park, Min S; Levitt, Michael R; Brinjikji, Waleed; Moss, Mark; Dumont, Travis; Williamson, Richard; Navia, Pedro; Kan, Peter; Leacy, Reade De; Chowdhry, Shakeel; Ezzeldin, Mohamad; Spiotta, Alejandro M; Kasab, Sami Al.
Affiliation
  • Elawady SS; Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, SC, USA.
  • Saway BF; Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, SC, USA.
  • Matsukawa H; Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, SC, USA.
  • Uchida K; Department of Neurosurgery, Hyogo Medical University, Nishinomiya, Japan.
  • Lin S; Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, SC, USA.
  • Maier I; Department of Neurosurgery, Hyogo Medical University, Nishinomiya, Japan.
  • Jabbour P; Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, SC, USA.
  • Kim JT; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
  • Wolfe SQ; Department of Neurosurgery, Thomas Jefferson University Hospitals, Philadelphia, PA, USA.
  • Rai A; Department of Neurology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, Korea.
  • Starke RM; Department of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Psychogios MN; Department of Radiology, West Virginia School of Medicine, Morgantown, WV, USA.
  • Samaniego EA; Department of Neurosurgery, University of Miami Health System, Miami, FL, USA.
  • Arthur A; Department of Interventional and Diagnostical Neuroradiology, University of Basel, Basel, Switzerland.
  • Yoshimura S; Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Cuellar H; Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Grossberg JA; Department of Neurosurgery, Hyogo Medical University, Nishinomiya, Japan.
  • Alawieh A; Department of Neurosurgery and Neurointerventional Radiology, Louisiana State University, Shreveport, LA, USA.
  • Romano DG; Department of Neurosurgery, Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.
  • Tanweer O; Department of Neurosurgery, Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.
  • Mascitelli J; Department of Neuroradiology, University Hospital San Giovanni di Dio e Ruggi d'Aragona, University of Salerno, Salerno, Italy.
  • Fragata I; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA.
  • Polifka A; Department of Neurosurgery, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Osbun J; Department of Neuroradiology, Hospital São José Centro Hospitalar, Lisboa, Portugal.
  • Crosa R; Department of Neurosurgery, University of Florida, Gainesville, FL, USA.
  • Matouk C; Department of Neurological Surgery, Washington University, St. Louis, MO, USA.
  • Park MS; Department of Neurosurgery, Endovascular Neurological Center, Montevideo, Uruguay.
  • Levitt MR; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
  • Brinjikji W; Department of Neurosurgery, University of Virginia, Charlottesville, VA, USA.
  • Moss M; Department of Neurosurgery, University of Washington, Seattle, WA, USA.
  • Dumont T; Department of Radiology, Mayo Clinic, Rochester, MN, USA; Department of Neurosurgery, Mayo Clinic, Rochester, MN, USA.
  • Williamson R; Department of Neuroradiology, Washington Regional J.B. Hunt Transport Services Neuroscience Institute, Fayetteville, AZ, USA.
  • Navia P; Department of Neurosurgery, University of Arizona, Tucson, AZ, USA.
  • Kan P; Department of Neurosurgery, Allegheny Health Network, Pittsburgh, PA, USA.
  • Leacy R; Department of Neuroradiology, Hospital Universitario La Paz, Madrid, Spain.
  • Chowdhry S; Department of Neurological Surgery, University of Texas Medical Branch - Galveston, TX, USA.
  • Ezzeldin M; Department of Neurosurgery, Mount Sinai Health System, New York, NY, USA.
  • Spiotta AM; Department of Neurosurgery, NorthShore University Health System, Evanston, IL, USA.
  • Kasab SA; University of Houston, Department of Clinical Neuroscience, HCA Houston Healthcare Kingwood, Houston, TX, USA.
J Stroke ; 26(1): 95-103, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38326708
ABSTRACT
BACKGROUND AND

PURPOSE:

Outcomes following mechanical thrombectomy (MT) are strongly correlated with successful recanalization, traditionally defined as modified Thrombolysis in Cerebral Infarction (mTICI) ≥2b. This retrospective cohort study aimed to compare the outcomes of patients with low Alberta Stroke Program Early Computed Tomography Score (ASPECTS; 2-5) who achieved mTICI 2b versus those who achieved mTICI 2c/3 after MT.

METHODS:

This study utilized data from the Stroke Thrombectomy and Aneurysm Registry (STAR), which combined databases from 32 thrombectomy-capable stroke centers between 2013 and 2023. The study included only patients with low ASPECTS who achieved mTICI 2b, 2c, or 3 after MT for internal carotid artery or middle cerebral artery (M1) stroke.

RESULTS:

Of the 10,229 patients who underwent MT, 234 met the inclusion criteria. Of those, 98 (41.9%) achieved mTICI 2b, and 136 (58.1%) achieved mTICI 2c/3. There were no significant differences in baseline characteristics between the two groups. The 90-day favorable outcome (modified Rankin Scale score 0-3) was significantly better in the mTICI 2c/3 group than in the mTICI 2b group (adjusted odds ratio 2.35; 95% confidence interval [CI] 1.18-4.81; P=0.02). Binomial logistic regression revealed that achieving mTICI 2c/3 was significantly associated with higher odds of a favorable 90-day outcome (odds ratio 2.14; 95% CI 1.07-4.41; P=0.04).

CONCLUSION:

In patients with low ASPECTS, achieving an mTICI 2c/3 score after MT is associated with a more favorable 90-day outcome. These findings suggest that mTICI 2c/3 is a better target for MT than mTICI 2b in patients with low ASPECTS.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Language: En Journal: J Stroke Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Language: En Journal: J Stroke Year: 2024 Document type: Article Affiliation country:
...